Observational studyPloS one2019

Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice.

Pablo Plaza-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.